An EBV-related CD4 TCR immunotherapy inhibits tumor growth in an HLA-DP5+ nasopharyngeal cancer mouse model.

Wang C, Chen J, Li J, Xu Z, Huang L, Zhao Q, Chen L, Liang X, Hu H, Li G, Xiong C, Wu B, You H, Du D, Wang X, Li H, Wang Z, Chen L
J Clin Invest. 2024 Feb 27;134(8):e172092. doi: 10.1172/JCI172092. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.